$23.85
+1.50 (+6.69%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
-48.0% upside
Low Target
$7.78
Average Target
$12.39
High Target
$16.73
Current Price
$23.85
Current
$23.85
$23.85
Target
$12.39
$12.39
$7.78
$12.39 avg
$16.73
Scenario Analysis
Bear Case
$7.78
-67.4%
Low target
Base Case
$12.39
-48.0%
Avg target
Bull Case
$16.73
+-29.8%
High target
Risk/Reward
0.4x
Unfavorable
Price in Context
52-Week High
$42.12
-43.4% from high
52-Week Low
$10.01
+138.3% from low
Target vs 52W High
$12.39
-70.6% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -3.3% |
| AMGN | Hold | 43 | 47% | $190.87 | -54.4% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +138.3% |
| VRTX | Strong Buy | 36 | 81% | $438.34 | -16.9% |
| REGN | Buy | 38 | 68% | $76.80 | -89.8% |
| MRNA | Hold | 30 | 37% | $149.45 | -24.2% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -65.3% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -43.4% |